Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer

Journal of Clinical Pharmacology - United States
doi 10.1177/0091270009335001
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Phase I/Ii Study of Oncolytic Herpes Simplex Virus NV1020 in Patients With Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Clinical Breast Cancer
Cancer ResearchOncology
2016English

A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer

Investigational New Drugs
OncologyPharmacology
2012English

A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Pembrolizumab Combined With Lenalidomide and Low‐dose Dexamethasone for Relapsed or Refractory Multiple Myeloma: Phase I KEYNOTE ‐023 Study

British Journal of Haematology
Hematology
2019English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study

British Journal of Cancer
Cancer ResearchOncology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy